Literature DB >> 23277392

Interethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations.

Marisol López1, Pedro Dorado, Alberto Ortega, Eva Peñas-Lledó, Nancy Monroy, Irma Silva-Zolezzi, Jesús Cobaleda, Alicia Gallego-Aguilera, María Elisa Alonso, Adrián Llerena.   

Abstract

UDP-glucuronosyltransferase 1A4 (UGT1A4) is a phase II drug-metabolizing enzyme that catalyzes the glucuronidation of many clinically-important drugs. Interethnic differences in the genetic polymorphism of UGT1A4 have been reported; however, there is no information in Mexican Mestizos (MMs) and Spaniards (SPs). Furthermore, MM is an admixed population with 26 % of Caucasian genes mainly from Spain. Therefore, this study aimed to investigate the potential differences between 318 SPs and 248 MMs healthy individuals regarding UGT1A4*1b, UGT1A4*2 and UGT1A4*3 alleles and to compare the observed frequencies with those previously reported in different populations. The allelic frequencies of the three UGT1A4 polymorphisms showed interethnic differences between MMs and SPs (p < 0.05). The analyzed SNPs variants in this genetic region were not in linkage disequilibrium (LD) for the MM population, suggesting that these mutations have arisen independently in the same genetic background. In contrast, UGT1A4*2 and UGT1A4*3 were in LD in the SP population. Comparison of present data with other in different ethnic groups revealed that the frequencies of UGT1A4*2 and UGT1A4*3 in SP were similar to other Caucasians and higher than in Asians, whereas in MMs were lower than in Caucasians and higher than in Asians only for UGT1A4*2. Present results could be helpful to improve the use of UGT1A4 drug substrates in order to adjust them to the ethnic background of a given population, specifically for Hispanics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23277392     DOI: 10.1007/s11033-012-2393-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  23 in total

1.  Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes.

Authors:  Miki Nakajima; Nozomi Sakata; Noriko Ohashi; Toshiyuki Kume; Tsuyoshi Yokoi
Journal:  Drug Metab Dispos       Date:  2002-11       Impact factor: 3.922

Review 2.  Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels.

Authors:  Karl Walter Bock
Journal:  Biochem Pharmacol       Date:  2010-05-08       Impact factor: 5.858

3.  Genetic admixture and diversity estimations in the Mexican Mestizo population from Mexico City using 15 STR polymorphic markers.

Authors:  Teresa Juárez-Cedillo; Joaquín Zuñiga; Victor Acuña-Alonzo; Nonanzit Pérez-Hernández; José Manuel Rodríguez-Pérez; Rodrigo Barquera; Guillermo J Gallardo; Rosalinda Sánchez-Arenas; Maria Del Carmen García-Peña; Julio Granados; Gilberto Vargas-Alarcón
Journal:  Forensic Sci Int Genet       Date:  2007-10-17       Impact factor: 4.882

4.  Functional analysis of UGT1A4(P24T) and UGT1A4(L48V) variant enzymes.

Authors:  Jin Zhou; Upendra A Argikar; Rory P Remmel
Journal:  Pharmacogenomics       Date:  2011-11-02       Impact factor: 2.533

Review 5.  Pharmacogenetics of the antiepileptic drugs phenytoin and lamotrigine.

Authors:  Marisol López; Pedro Dorado; Nancy Monroy; María Elisa Alonso; Helgi Jung-Cook; Esther Machín; Eva Peñas-Lledó; Adrián Llerena
Journal:  Drug Metabol Drug Interact       Date:  2011

6.  UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation.

Authors:  Asami Mori; Yoshihiro Maruo; Masaru Iwai; Hiroshi Sato; Yoshihiro Takeuchi
Journal:  Drug Metab Dispos       Date:  2005-02-11       Impact factor: 3.922

Review 7.  N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.

Authors:  Sanna Kaivosaari; Moshe Finel; Mikko Koskinen
Journal:  Xenobiotica       Date:  2011-03-24       Impact factor: 1.908

Review 8.  Pharmacogenetics and irinotecan therapy.

Authors:  Kristine K Hahn; James J Wolff; Jill M Kolesar
Journal:  Am J Health Syst Pharm       Date:  2006-11-15       Impact factor: 2.637

9.  Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.

Authors:  Doris Wiener; Daniel R Doerge; Jia-Long Fang; Pramod Upadhyaya; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2004-01       Impact factor: 3.922

10.  Searching for tissue-specific expression pattern-linked nucleotides of UGT1A isoforms.

Authors:  Wei Zhang; Wanqing Liu; Federico Innocenti; Mark J Ratain
Journal:  PLoS One       Date:  2007-04-25       Impact factor: 3.240

View more
  2 in total

1.  Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigine.

Authors:  Arne Reimers; Wenche Sjursen; Grethe Helde; Eylert Brodtkorb
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-12-10       Impact factor: 2.441

2.  Rash and multiorgan dysfunction following lamotrigine: could genetic be involved?

Authors:  Alessio Provenzani; Manuela Labbozzetta; Monica Notarbartolo; Paola Poma; Piera Polidori; Giovanni Vizzini; Natale D'Alessandro
Journal:  Int J Clin Pharm       Date:  2015-07-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.